The size of the Europe Varicose Vein Treatment Market is valued USD 95.4 million in 2019 and estimated to be growing at a CAGR of 6.3%, to reach USD 129.49 million by 2024 during the forecast period 2019 - 2024.
Growth factors for Europe Varicose Vein Treatment Market include increased patient compliance and reliability, increased healthcare costs, and rapid growth in aging. The varicose vein treatment market in Europe is mainly due to the emergence of durable and safe technologies to address the enormous burden of varicose veins and increased access to varicose vein medical devices, owing to patient compliance. Furthermore, there is a new trend in the healthcare industry to remove or destroy superficial veins, improving the patient experience.
Europe Varicose Vein Treatment Market growth in future is further driven by an increased incidence of varicose veins, an increasing elderly population, advanced varicose vein treatment devices, occupational involvement in increasing the prevalence of varicose veins, and technological advances. Also, increasing levels of awareness and the development of emerging markets have created many opportunities in the Europe Varicose Vein Treatment Market.
Europe Varicose Vein Treatment Market analysis is performed comprehensively in primary and secondary regions to understand growth factors and factors that hinder the market growth.
The challenges associated with inconsistent reimbursement scenarios in treatment procedures, and the sustainability of key players in this highly competitive marketplace can limit European Market growth.
This research report segmented and sub-segmented the Europe Varicose Vein Treatment Market into the following categories and evaluated market size and forecast to each segment until 2024.
Regionally, the aggressive action of the European government and the growing popularity of advanced therapies are supposed to have a positive impact on market growth. As of 2019, the European varicose vein treatment device market is transitioning to non-invasive medical procedures and expensive surgical procedures for vena cava treatment.
Europe Varicose Vein Treatment Market is likely to be the fastest-growing market due to the developing healthcare infrastructure, rise in patient awareness, soaring disposable income, and benefits of early treatments for varicose vein cases in nations like the UK, Germany, France, Spain, Italy, Norway and others.
Some of the Promising Companies leading the Europe Varicose Vein Treatment Market Profiled in the Report are Medtronic plc (Ireland), AngioDynamics, Inc. (U.S.), biolitec AG (Austria), Syneron Medical Ltd. (Israel), Lumenis Ltd. (Israel), Dornier MedTech GmbH (Germany), Energist Group (U.K.), Eufoton s.r.l. (Italy), Vascular Solutions, Inc. (U.S.), Quanta System S.p.A. (Italy), Sciton, Inc. (U.S.), Fotona d.o.o. (Slovenia), BTG plc (U.K.), Merz Aesthetics (U.S.)
1.1 Market Definition
1.2 Study Deliverables
1.3 Base Currency, Base Year and Forecast Periods
1.4 General Study Assumptions
2. Research Methodology
2.2 Research Phases
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 Econometric Modelling
2.2.4 Expert Validation
2.3 Analysis Design
2.4 Study Timeline
3.1 Executive Summary
3.2 Key Inferences
4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
4.1 Market Drivers
4.2 Market Restraints
4.3 Key Challenges
4.4 Current Opportunities in the Market
5. Market Segmentation
5.1.2 Endovenous ablation
5.1.3 Surgical litigation/ Stripping
5.1.5 Y-o-Y Growth Analysis, By Treatment
5.1.6 Market Attractiveness Analysis, By Treatment
5.1.7 Market Share Analysis, By Treatment
5.2.2 Ablation devices
220.127.116.11 Radiofrequency ablation devices
18.104.22.168. Laser ablation devices
5.2.3 Venous closure products
5.2.4 Surgical products
5.2.5 Y-o-Y Growth Analysis, By Product
5.2.6 Market Attractiveness Analysis, By Product
5.2.7 Market Share Analysis, By Product
6. Geographical Analysis
6.1.1 Regional Trends
6.1.2 Impact Analysis
6.1.3 Y-o-Y Growth Analysis
22.214.171.124 By Geographical Area
126.96.36.199 By Treatment
188.8.131.52 By Product
6.1.4 Market Attractiveness Analysis
184.108.40.206 By Geographical Area
220.127.116.11 By Treatment
18.104.22.168 By Product
6.1.5 Market Share Analysis
22.214.171.124 By Geographical Area
126.96.36.199 By Treatment
188.8.131.52 By Product
7.1 PESTLE analysis
7.2 Porter’s Five analysis
7.2.1 Bargaining Power of Suppliers
7.2.2 Bargaining Power of Consumers
7.2.3 Threat of New Entrants
7.2.4 Threat of Substitute Products and Services
7.2.5 Competitive Rivalry within the Industry
8.Market Leaders' Analysis
8.1 Medtronic plc
8.1.2 Product Analysis
8.1.3 Financial analysis
8.1.4 Recent Developments
8.1.5 SWOT analysis
8.1.6 Analyst View
8.2 AngioDynamics, Inc.
8.3 Syneron Medical Ltd.
8.4 Lumenis Ltd.
8.5 Dornier MedTech GmbH
8.6 Energist Group
8.7 Vascular Solutions, Inc.
8.8 Merz Aesthetics
9.1 Market share analysis
9.2 Merger and Acquisition Analysis
9.3 Agreements, collaborations and Joint Ventures
9.4 New Product Launches
10.Market Outlook and Investment Opportunities
a) List of Tables
b) List of Figures